# GlucoShield — Phase 7A Executive Summary & Feasibility Report
**Document ID:** `GLUCOSHIELD-RPT-PHASE7A-EXEC-001`  
**Timestamp:** 2026-08-28T16:01:00 Local Time  
**Author:** Lead Deep Learning & Physiological Systems Engineer  
**Status:** **AUDIT & PLANNING COMPLETE (V1 PRESERVED FROZEN)**  

---

## 1. Audit Synthesis: What V1 Already Has vs. What V2 Should Add

```
===============================================================================
GLUCOSHIELD V1 (FROZEN REFERENCE BASELINE)
===============================================================================
• Data: 112 patients, 28,447 sequences (ShanghaiT1D/T2D, 15-min uniform grid)
• Dynamic Inputs (22 Channels): CGM, Velocity, Accel, Rolling Stats (1h, 3h, 6h),
  Circadian Sine/Cosine/Night, Basal/Bolus/Total Insulin, IOB, Carbs, Meal Flag,
  COB, 2h Cumulative Loads.
• Static Biomarkers (9 Features): Age, BMI, HbA1c, Glycated Albumin, Fasting Glucose,
  Fasting C-peptide, Macrovascular/Microvascular Counts, T1D indicator.
• Core Engine: Multi-Task GRU-128 + 6-Compartment ODE Digital Twin + Adaptive Gate.
• Validated Metrics on Test Set (N=4,113): MAE = 24.14 mg/dL, RMSE = 34.77 mg/dL,
  Clarke A+B = 95.36%, Wilcoxon p = 0.0039 vs. GRU.

===============================================================================
GLUCOSHIELD V2 PROPOSED MULTIMODAL ADDITIONS
===============================================================================
1. Upstream Multi-Modal Food Vision:
   • Solves the #1 Phase 6 Failure Mode (+51.2% error spike on unlogged meals).
   • Trained on Nutrition5k / NutritionVerse (5,000 lab-measured RGB dishes).
   • Automatically outputs [Carbohydrates (g), Protein (g), Total Fat (g)].
2. Wearable Physical Activity & Exertion:
   • 15-minute resampled Step Counts and Heart Rate (HR).
   • Trained on co-recorded longitudinal benchmarks (OhioT1DM / D1NAMO).
   • Adds non-insulin muscle GLUT-4 glucose clearance to the ODE Digital Twin.
3. Scientifically Rejected Features:
   • Trans fat / saturated fat separate acute tracking (negligible acute 5h predictive value).
   • Unsynchronized consumer smartwatch data without matching CGM.
   • Unrelated patient signal stitching (Chimera records).
```

---

## 2. Master Deliverables Manifest for Phase 7A

| Document Name | File Path | Focus & Purpose |
|---|---|---|
| **Multimodal Data Audit** | [`research/phase7a/MULTIMODAL_DATA_AUDIT.md`](file:///D:/ML%20PROJECT/research/phase7a/MULTIMODAL_DATA_AUDIT.md) | In-depth breakdown of current 22 dynamic + 9 static features, candidate feature classifications. |
| **Dataset Acquisition Matrix** | [`research/phase7a/DATASET_ACQUISITION_MATRIX.md`](file:///D:/ML%20PROJECT/research/phase7a/DATASET_ACQUISITION_MATRIX.md) | Analysis of OhioT1DM, D1NAMO, OpenAPS, Nutrition5k, NutritionVerse with access requirements. |
| **Smartwatch Feasibility Checklist** | [`research/phase7a/SMARTWATCH_FEASIBILITY_CHECKLIST.md`](file:///D:/ML%20PROJECT/research/phase7a/SMARTWATCH_FEASIBILITY_CHECKLIST.md) | 10 mandatory technical criteria required before using any consumer smartwatch. |
| **V2 Architecture Options** | [`research/phase7a/V2_ARCHITECTURE_OPTIONS.md`](file:///D:/ML%20PROJECT/research/phase7a/V2_ARCHITECTURE_OPTIONS.md) | Detailed architecture specs for Option A (Vision), Option B (Vision+Wearables), Option C (Universal Platform). |
| **Scientific Prioritization & Roadmap** | [`research/phase7a/PHASE7A_RECOMMENDED_ROADMAP.md`](file:///D:/ML%20PROJECT/research/phase7a/PHASE7A_RECOMMENDED_ROADMAP.md) | Scientific feature ranking and 3-phase implementation roadmap. |

---
*GlucoShield Phase 7A Feasibility Audit Certified. Awaiting single user approval before Phase 7B execution.*
